Cibus to Participate in the 36th Annual Roth Conference

Rhea-AI Summary

Cibus, Inc. (CBUS) announced participation in the 36th Annual Roth Conference to discuss gene editing in agriculture and the implications of a post-GMO era.

SAN DIEGO, March 13, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that Rory Riggs, Co-Founder, Chief Executive Officer, and Chairman, and Peter Beetham, Co-Founder, President, and Chief Operating Officer will participate in a panel at the 36^th Annual Roth Conference taking place March 17-19, 2024.

Panel Title: AgTech Panel – Gene Editing in Ag and Implications of a Post GMO Era

Date: Monday, March 18, 2024

Time: 3:00 p.m. PT (6:00 p.m. ET)        

Webcast link: https://wsw.com/webcast/roth48/panel26/2119832

About Cibus

Cibus is a leader in Gene Edited Productivity traits that address critical productivity and sustainability challenges for farmers such as diseases and pests which the United Nations estimates cost the global economy approximately $300 billion annually. Cibus is not a seed company. It is a technology company that uses gene editing to develop and license traits to seed companies in exchange for royalties on seed sales. Cibus’ focus is productivity traits for the major global crops such as canola, rice, soybean, and wheat. Cibus is a technology leader in high throughput gene editing technology that enables Cibus to develop and commercialize plant traits at a fraction of the time and cost of conventional breeding. Cibus has developed a pipeline of five productivity traits including important traits for pod shatter reduction, Sclerotinia resistance and weed management. Its initial traits for pod shatter reduction and weed management are developed in collaborations with leading seed companies. Its other pipeline traits including Sclerotinia resistance are in advanced greenhouse and field trial stages.

Cibus Contacts:

Investor Relations
Karen Troeber
ktroeber@cibus.com
858-450-2636

Jeff Sonnek – ICR
jeff.sonnek@icrinc.com

Media Relations

Colin Sanford
colin@bioscribe.com
203-918-4347

FAQ

What is the panel title where Cibus, Inc. executives will participate?

The panel title is 'AgTech Panel – Gene Editing in Ag and Implications of a Post GMO Era'.

When is the panel scheduled to take place?

The panel is scheduled for Monday, March 18, 2024.

Who are the executives from Cibus, Inc. participating in the panel?

Rory Riggs, Co-Founder, CEO, and Chairman, and Peter Beetham, Co-Founder, President, and COO will participate.

Where can the webcast of the panel be accessed?

The webcast link is https://wsw.com/webcast/roth48/panel26/2119832.